BNC Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,603
Closed -$1.85M 111
2022
Q4
$1.85M Buy
3,603
+31
+0.9% +$15.7K 1.09% 32
2022
Q3
$1.62M Sell
3,572
-82
-2% -$39.2K 0.98% 36
2022
Q2
$1.76M Sell
3,654
-262
-7% -$130K 0.92% 35
2022
Q1
$1.92M Buy
+3,916
New +$1.79M 0.95% 32
2020
Q4
Sell
-21
Closed -$6K 213
2020
Q3
$6K Buy
+21
New +$5.65K ﹤0.01% 351

Other funds holding ELV

BNC Wealth Management's ELV Position: Q1 2023 in Review

BNC Wealth Management sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 3,603 shares — an estimated $1.85M sold.

BNC Wealth Management first reported a position in ELV in Q3 2020 and held it in 5 quarters. The position peaked at $1.92M in Q1 2022. 1,516 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

  • BNC Wealth Management reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
  • BNC Wealth Management sold 3,603 Elevance Health shares in Q1 2023, an estimated $1.85M.
  • BNC Wealth Management first reported a position in Elevance Health in Q3 2020 and held it in 5 quarters.
  • BNC Wealth Management's Elevance Health position peaked at $1.92M in Q1 2022.
  • 1,516 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on BNC Wealth Management's 13F filing for Q1 2023, filed 21 Apr 2023.